Bjørn Tore G.
- Country
- Norway
- Department
- Department of Medicine
Research Overview
- Evaluation of CC-95251 Monotherapy and in Combination with Antineoplastic Agents in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes
- A Phase 1 Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Vididencel in Chronic Phase Chronic Myeloid Leukemia Patients with Measurable Residual Disease
- Evaluation of Acalabrutinib Monotherapy in Treatment-Naive or Relapsed/Refractory Chronic Lymphocytic Leukemia: A Phase 3b, Multicenter, Open-Label Study
Data & Insights
Has run more than one trial at 147 of 279 partner sites.
Specializations
Haematologic Malignancies
Clinical research in acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndromes, chronic lymphocytic leukemia, follicular lymphoma, mantle cell lymphoma, diffuse large B-cell lymphoma, and multiple myeloma, with additional involvement in Hodgkin lymphoma and other aggressive B-cell neoplasms.
- Leukemia
- Lymphoma
- Myelodysplastic syndromes
- Multiple myeloma
The therapeutic profile also includes pediatric hematology, relapsed and refractory disease, and treatment strategies aimed at improving disease control in high-risk blood cancers.
Thoracic and Upper Aerodigestive Cancers
Active involvement in non-small cell lung cancer, small-cell lung cancer, head and neck squamous cell carcinoma, head and neck cancer, esophageal-region malignancies, and mesothelioma, alongside studies in advanced solid tumors with actionable molecular features such as KRAS G12C, EGFR, and PD-L1 expression.
- Non-small cell lung cancer
- Small-cell lung cancer
- Head and neck squamous cell carcinoma
- Mesothelioma
Research interests extend to immunotherapy, targeted therapy, and combined modality treatment in locally advanced and metastatic thoracic and head-and-neck oncology.
Gastrointestinal and Hepatobiliary Oncology
Clinical trial activity covers colorectal cancer, colon cancer, pancreatic cancer, biliary adenocarcinoma, hepatocellular carcinoma, primary sclerosing cholangitis, gastrointestinal stromal tumor, and neuroendocrine tumors, including advanced and metastatic disease settings.
- Colorectal cancer
- Pancreatic cancer
- Biliary tract cancer
- Gastrointestinal stromal tumor
The therapeutic emphasis includes checkpoint inhibition, chemotherapy, and treatment innovation for hepatobiliary and lower gastrointestinal malignancies.
Melanoma and Other Solid Tumors
Research spans cutaneous malignant melanoma, stage III melanoma, stage IIB/C melanoma, breast cancer, endometrial carcinoma, cervical cancer, ovarian cancer, urothelial carcinoma, and renal cancer, with attention to both resectable and advanced disease.
- Melanoma
- Breast cancer
- Endometrial carcinoma
- Urothelial carcinoma
Additional interests include adjuvant therapy, perioperative treatment, and biomarker-defined approaches in advanced solid tumors.
Neurology, Immune-Mediated, and Inflammatory Disorders
Clinical involvement also includes multiple sclerosis, myasthenia gravis, migraine, pulmonary sarcoidosis, idiopathic pulmonary fibrosis, rheumatoid arthritis, Crohn's disease, psoriasis, and immune thrombocytopenia, together with selected cardiovascular and metabolic conditions.
- Multiple sclerosis
- Migraine
- Autoimmune disease
- Inflammatory lung disease
The therapeutic scope includes immunomodulation, anti-inflammatory treatment, and management of chronic immune-driven disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.